Skip to main content
. 2023 Dec 27;16(1):135. doi: 10.3390/cancers16010135

Table 1.

Patient characteristics for 27,088 colorectal cancer patients treated in Finland, 2006–2015.

Patient Characteristics
<75 Years Old ≥75 Years Old 75–79 Years Old 80–84 Years Old 85–89 Years Old ≥90 Years Old
n  (%) n  (%) n  (%) n  (%) n  (%) n  (%)
All 15,782 11,306 4287 3745 2342 932
Gender
Male 9035 (57.2) 5194 (45.9) 2302 (53.7) 1732 (46.2) 877 (37.4) 283 (30.4)
Female 6747 (42.8) 6112 (54.1) 1985 (46.3) 2013 (53.8) 1465 (62.6) 649 (69.6)
FCR classification 1
0 2375 (15.1) 2641 (23.4) 807 (18.8) 803 (21.5) 654 (27.9) 374 (40.1)
1 2782 (17.6) 1919 (17.0) 776 (18.1) 644 (17.2) 382 (16.3) 117 (12.6)
2 2565 (16.3) 1321 (11.7) 557 (13.0) 449 (12.0) 237 (10.1) 80 (8.6)
3 2859 (18.1) 2367 (20.9) 930 (21.7) 815 (21.8) 468 (20.0) 154 (16.5)
4 1166 (7.4) 891 (7.9) 321 (7.5) 311 (8.3) 185 (7.9) 74 (7.9)
5 2233 (14.1) 1362 (12.0) 550 (12.8) 456 (12.2) 270 (11.5) 86 (9.2)
6 1802 (11.4) 803 (7.1) 346 (8.1) 264 (7.0) 146 (6.3) 47 (5.1)
Tumor location
Right colon 4228 (26.8) 4160 (36.8) 1476 (34.4) 1433 (38.3) 914 (39.0) 337 (36.1)
Left colon 4016 (25.5) 2478 (21.9) 1028 (24.0) 800 (21.3) 477 (20.4) 173 (18.6)
Rectum 6651 (42.1) 3650 (32.3) 1490 (34.8) 1179 (31.5) 711 (30.4) 270 (29.0)
Other 887 (5.6) 1018 (9.0) 293 (6.8) 333 (8.9) 240 (10.2) 152 (16.3)
Operative treatment
Resection 6878 (43.6) 5146 (45.5) 2071 (48.3) 1816 (48.5) 971 (41.5) 288 (30.9)
No resection 738 (4.7) 314 (2.8) 144 (3.4) 102 (2.7) 54 (2.3) 14 (1.5)
No information/no surgery 8166 (51.7) 5846 (51.7) 2072 (48.3) 1827 (48.8) 1317 (56.2) 630 (67.6)
Postoperative hospital stay, median in
days (IQR)
Colon cancer 6.0 (4.0–8.0) 7.0 (5.0–10.0) 7.0 (5.0–9.0) 7.0 (5.0–10.0) 7.0 (5.0–10.0) 7.0 (5.0–10.0)
Rectum cancer 7.0 (5.0–9.0) 7.0 (5.0–10.0) 7.0 (5.0–10.0) 7.0 (6.0–10.0) 7.0 (5.0–9.5) 7.0 (6.0–9.0)

1 FCR, Finnish Cancer Registry classes: 0, unknown; 1, localized; 2, non-localized, regional lymph node metastasis only; 3, metastasized further than to regional lymph nodes or invading adjacent tissues; 4, non-localized, no information on extent; 5, locally advanced, tumor invasion to adjacent tissues; and 6, non-localized, including distant lymph node metastasis.